UK becomes the first country to approve antiviral COVID-19 pill

Antiviral drug Lagevrio (molnupiravir), developed by Ridgeback Biotherapeutics and Merck Sharp and Dohme (MSD), has been approved by the UK after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19